LC
Laurencin Cato T
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Laurencin Cato T, Director. Director active across 2 companies, notably Mimedx Group, INC.. Aggregated, 17 filings have been published. Activity tracked since 27 May 2021. The latest transaction was disclosed on 21 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Laurencin Cato T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
6,142 sharesOrdinary SharesSEC:0001520262-26-000088:0
1,475 shares@ US$36.950.0010% mcap19.3% of flowOrdinary SharesSEC:0001520262-26-000088:1
28,609 shares@ US$6.4720.5% of flowCommon StockSEC:0001376339-25-000066:0
8,013 sharesOrdinary SharesSEC:0001127602-25-016200:0
4,163 sharesOrdinary SharesSEC:0001127602-24-028884:0
6,104 sharesOrdinary SharesSEC:0001127602-24-019597:0
23,190 shares@ US$7.2620.2% of flowCommon StockSEC:0001376339-24-000052:0
2,690 shares@ US$22.5223.2% of flowOrdinary SharesSEC:0001127602-24-005339:0
4,163 sharesOrdinary SharesSEC:0001127602-23-029515:0
1,000 shares@ US$25.869.8% of flowOrdinary SharesSEC:0001127602-23-029515:1
5,957 sharesOrdinary SharesSEC:0001127602-23-020548:0
35,354 shares@ US$4.9521.1% of flowCommon StockSEC:0001376339-23-000036:0
2,638 shares@ US$22.9723.1% of flowOrdinary SharesSEC:0001127602-23-018291:0
2,800 shares@ US$22.9724.7% of flowOrdinary SharesSEC:0001127602-23-018168:0
4,160 sharesOrdinary SharesSEC:0001127602-22-027226:0
44,191 shares@ US$3.960.016% mcap36.3% of flowCommon StockSEC:0001444810-22-000004:0
17,056 shares@ US$10.2618.3% of flowCommon StockSEC:0001444810-21-000002:0
About Laurencin Cato T
LAURENCIN CATO T is Administrateur and has 17 filings in total. In the sampled recent filings, there are no buy or sell amounts, the most frequent transaction nature is Levée d'options, and the period runs from 2021-05-28 to 2026-05-22. The recent filings concern Mimedx Group, INC. and Alkermes plc., with individual amounts of EUR 163569.0945897161, EUR 162199.1268578712, EUR 161272.2850973496, EUR 154819.9313516878, EUR 143518.2910515792, and EUR 60066.64313767054.